Activity of doripenem and comparator -lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin-binding domains of pbp1a, pbp2b and pbp2x
Authors:
Open Access
- 31 January 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 61 (3) , 751-753
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum -lactamase PER-1 and metallo- -lactamase VIM-2 from TurkeyJournal of Antimicrobial Chemotherapy, 2007
- Activities of Ceftobiprole and Other β-Lactams against Streptococcus pneumoniae Clinical Isolates from the United States with Defined Substitutions in Penicillin-Binding Proteins PBP 1a, PBP 2b, and PBP 2xAntimicrobial Agents and Chemotherapy, 2006
- Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsJournal of Antimicrobial Chemotherapy, 2004
- Complete Sequences of Six Penicillin-Binding Protein Genes from 40 Streptococcus pneumoniae Clinical Isolates Collected in JapanAntimicrobial Agents and Chemotherapy, 2004
- Acquisition of Five High- M r Penicillin-Binding Protein Variants during Transfer of High-Level β-Lactam Resistance from Streptococcus mitis to Streptococcus pneumoniaeJournal of Bacteriology, 1998